Adding Senna alkaloid to laxative agents in bowel preparation for pediatric colonoscopy: a clinical trial study

Seyedeh Maryam Mahdavi Mortazavi1, Mohammad Hadi Immanieh2, Naser Honar1

  • 1Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pediatric gastroenterology and hepatology, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Adding Senna alkaloid syrup to laxative agents significantly improved bowel preparation for pediatric colonoscopy. This enhanced method resulted in better colon cleansing and no reported side effects, suggesting its potential as a standard practice.

Area of Science:

  • Pediatric Gastroenterology
  • Endoscopy Procedures
  • Pharmacological Interventions

Background:

  • Effective bowel preparation is essential for successful pediatric colonoscopy.
  • Current laxative agents may have limitations in achieving optimal colon cleansing in children.

Purpose of the Study:

  • To evaluate the efficacy and safety of adding Senna alkaloid syrup to conventional laxative agents for bowel preparation in children undergoing colonoscopy.

Main Methods:

  • A double-blind, controlled trial was conducted with 64 pediatric patients randomized into two groups.
  • One group received conventional laxatives, while the other received conventional agents plus Senna alkaloid syrup (polyethylene glycol-3350).
  • Colon cleansing was assessed using the Aronchick Scale, with safety evaluations performed.

Main Results:

  • The Senna group demonstrated statistically significant improvement in colon cleansing compared to the conventional group (p < 0.001).
  • No children in the Senna group required repeat bowel preparation.
  • No adverse side effects were reported in either the Senna or control groups.

Conclusions:

  • Incorporating Senna alkaloid syrup into bowel preparation protocols enhances colon cleansing efficacy for pediatric colonoscopy.
  • This approach appears safe and may represent a valuable addition to standard pediatric colonoscopy preparation.
  • Further integration into routine practice is suggested based on positive outcomes.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
718
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.3K
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
1.0K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
734
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
605